---
layout: post
title: "东亚药业：拟发行不超7亿元可转债"
date: 2022-05-31 19:21:15 +0800
categories: zhengquanshibao·quanzhongshe
tags: 证券时报·券中社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.605177" data-code="605177|1|1" data-code2="605177|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.605177&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 605177_0" data-code="K 605177|1|1" data-code2="K 605177|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>券中社5月31日讯，东亚药业披露公开发行可转换公司债券预案，拟募集资金总额不超过7亿元，用于特色新型药物制剂研发与生产基地建设项目(一期)、年产3685吨医药及中间体、4320吨副产盐项目(一期)。 <br /></p><p class="em_media">（文章来源：证券时报·券中社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205312398093028>

[返回证券时报·券中社新闻](//finews.withounder.com/category/zhengquanshibao·quanzhongshe.html)｜[返回首页](//finews.withounder.com/)